- Me: Is there anything new to report about
your vaccine? Are there any newly pioneered domains of
- research being applied to your vaccine
today?
- Dr.
Blumberg replied that the vaccine has been in effect for over 10 years, and that he is
proud of recent
- reports from several locations
worldwide, telling of HBV frequency rates dropping from 12-15% in areas such as
- Korea and Taiwan to a mere 1-2%. In Japan,
rates have dropped from 2-#% to 0.1-0.2% incidence. A dramatic drop
- of HBV carriers has occured in North
America as well.
-
In terms of new research, there are always studies going on to improve on the
effectiveness of the vaccine in
- order to better preventative techniques.
Taiwan recently came out with a population study in which the national
- immunization policy was examined for
efficacy. Results illustrated a 2/3 incidence drop of 40-50 year olds with
- liver cancer due to their having been
immunized on or before age 10. Dr. Blumberg then emphasized the fact that
- liver cancer is responsible for 85% of the
world's primary cancer cases, second only to lung cancer. The fact that
- liver cancer can be controlled in this way
gives future generations hope for successful prevention of something that
- has in the past thought to have been
incurable.
-
- *Me: If the HBV vaccine can be used to study
possible ways of combatting cancer. Is there any way its
- principle methods can be applied to a future
HIV vaccine? If HBV is even more infectious, why hasn't it
- received as much press?
- Dr. Blumberg replied, "People aren't as upset
by it" and therefore are less likely to fund it. Reality is that
- HBV affects the same population group as
HIV, but is not as prevalent a problem in North America as it is
- in Asia or Africa. The initial response to
AIDS occurred due to the fact that everyone seemed to die from HIV.
- Acute Hepatitis B is usually cured, and
incidence of chronic Hepatitis B varied as well as its mortality rates.
- For most people, AIDS is a scarier thing.
-
- *Me: Are there any barriers to the success of
your vaccine today?
- Not everyone responds to the vaccine, although it has a
success rate of about 95%. There is a possibility
- for the need to develop a new vaccine
should HBV start to become resistant to the current vaccine. However,
- that does not seem likely for sometime.
What does pose a great problem today are countries such as those
- in Africa, where there are only 4-5
vaccination centers for 30-40 countries. There is a great economic barrier
- there in comparison to Asia, India being
an exception where immunization programs are nonexistent as well.
-
- *Me: OK. Now I want to get to what the other
interview didn't dare ask. I'm curious. Where does one keep a
- Nobel Prize? Is it like an Oscar, displayed
on your mantle somewhere?
- The Nobel Prize is actually a big gold medallion,
and right now I think it's sitting in a safe in Philidelphia.
-
- *Me: When you are not busy saving people's
lives, what do you like to do for fun?
- Dr. Blumberg told me he enjoyed being in nature:
canoeing, hiking, and biking.
-
- *Me: I know you've travelled almost
everywhere in the world. But if you could choose to be somewhere right
- now, where would it be?
- Home in Philidelphia with my wife (so sweet!) Dr.
Blumberg also mentioned wanting to visit his four children,
- two of whom are residing in England.
-
- *Me: What is your favorite book?
- Conrad books: Lord Jim , Heart of
Darkness...
-
- Interview conducted Monday March 2, 1999.